UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumors
February 03, 2026
February 03, 2026
LOS ANGELES, California, Feb. 3 -- The University of California posted the following news release:
* * *
UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumors
*
Findings
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, or . . .
* * *
UCLA scientists identify optimal design for off-the-shelf immunotherapy targeting solid tumors
*
Findings
A UCLA research team has identified the best design for a promising new type of immunotherapy that could be mass-produced to treat multiple solid tumors. The study focused on engineered invariant natural killer T cells, or . . .